Revolution Medicines Inc (RVMD) vs peers

$188.72

Latest weekly close · Market cap $39.8B

RVMD's P/S is not meaningful or is unavailable. Choose another measure to compare peers.

Peer group: Biotechnology. Updated Oct 29, 2026.

RVMD and Biotechnology, ranked by P/S
Stock	P/S	Own 5-year percentile
RVMDRevolution Medicines Inc	n/m	n/m, not ranked
MRNAModerna	38.3×	99
NTRANatera Inc	22.5×	100
VRTXVertex Pharmaceuticals	10.7×	72
ABBVAbbVie	7.9×	100
GILDGilead Sciences	6.5×	99
AMGNAmgen	6.5×	99
REGNRegeneron Pharmaceuticals	5.6×	41
BIIBBiogen	3.5×	73
Peer median	7.2×

How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

P/S divides market value by revenue over the last twelve months. The peer median leaves out RVMD and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its P/S is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive revenue have no reading.

RVMD versus the peer median

n/m

RVMD: n/m
Peer median: 7.2×
Own 5-year median: 72.9×

RVMD P/S history Calculate RVMD's implied price